MDWD
HealthcareMediWound Ltd.
$18.48
+$0.06 (+0.33%)
Jan 5, 2026
Price History (1Y)
Analysis
MediWound Ltd. is a biotechnology company in the healthcare sector with a market capitalization of $236.94M and approximately 111 employees. It operates within the larger biotechnology industry. The company's financial health is characterized by significant losses. Its revenue (TTM) stands at $20.93M, while it incurred net income of -$20,604,000 (TTM). The operating margin was -120.2%, and the profit margin was -98.4%. MediWound also reported EBITDA of -$22,664,000 and free cash flow of -$15,193,375. However, the company maintains a relatively healthy balance sheet with $59.09M in cash and $8.27M in debt. MediWound's valuation is marked by a forward P/E ratio of -7.59, which indicates a negative earnings growth expectation. The price to book ratio stands at 4.72, while the price to sales ratio is 11.32. The company has not paid any dividends, and its dividend yield is N/A. Its revenue growth (YoY) was 24.7%, but its earnings growth rate is N/A due to significant losses.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Visit website →Key Statistics
- Market Cap
- $236.94M
- P/E Ratio
- N/A
- 52-Week High
- $22.50
- 52-Week Low
- $14.14
- Avg Volume
- 74.26K
- Beta
- 0.07
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- Israel
- Employees
- 111